The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat

Neuroscience

Volumn 70, Issue 3, 1996, Pages 749-754

  PrzewLocka B ^a   Turchan, J ^a   Lason W ^a   PrzewLocki R ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

morphine; nucleus accumbens; prodynorphin mRNA; rat; striatum; neoendorphin

Indexed keywords

MESSENGER RNA; MORPHINE; PRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 0342468857     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)83012-0     Document Type: Article

References (35)

1. Acquas E., Carboni E. and Di Chiara G. (1991) Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmac. 193, 133-134.
2. Acquas E. and Di Chiara G. (1992) Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58, 139-142.
3. Bals-Kubik R., Herz A. and Shippenberg T. S. (1989) Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated. Psychopharmacology 98, 203-206.
4. Bronstein D. M., Przewłocki R. and Akil H. (1990) Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res, 519, 102-111.
5. Chavkin C., James I. F. and Goldstein A. (1982) Dynorphin is a specific endogenous ligand of kappa opioid receptor. Science 215, 413-415.
6. Di Chiara G, and Imperato A, (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmac. exp. Ther. 244, 1067-1080.
7. Green P. G. and Lee N. M. (1988) Dynorphin A (1-13) attenuates withdrawal in morphine-dependent rats: effects of route of administration. Eur. J. Pharmac. 145, 267-272.
8. Hanson G. R., Merchant K. M., Letter A. A., Bush L. and Gibb J. W., (1988) Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur. J. Pharmac. 155, 11-18.
9. Höllt V., Haarmann I. and Reimer S. (1989) Opioid gene expression in rats after chronic morphine treatment. Adv. Biosci. 75, 711-714.
10. Koob G. F., Wall T. L. and Bloom F. E. (1989) Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98, 530-534.
11. Mocchetti A., Ritter A. and Costa E. (1989) Down-regulation of proopiomelanocortin synthesis and β-endorphin utilization in hypothalamus of morphine-tolerant rats. J. molec. Neurosci. 1, 33-38.
12. Morris B. J., Höllt V. and Herz A. (1988) Opioid gene expression in rat striatum is modulated via opioid receptors: evidence from localized receptor inactivation. Neurosci. Lett. 89, 80-84.
13. Mucha R. F. and Herz A. (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning procedures. Psychopharmacology 86, 274-280.
14. Pfeiffer A., Brantl V., Herz A. and Emrich H. (1986) Psychotomimesis mediated by κ-opiate receptors. Science 233, 774-776.
15. Przewłocka B. and Lasoń W. (1991) The effect of single and repeated ethanol administration on hypothalamic opioid systems activity - an in vitro release study. Drug Alcohol Dep. 27, 63-67.
16. Przewłocka B., Lasoń W. and Przewłocki R. (1994) The effect of chronic morphine and cocaine administration on the Gs and Go protein messenger RNA levels in the rat hippocampus. Neuroscience 63, 1111-1116.
17. Przewłocki R., Lasoń W., Höllt V., Silberring J. and Herz A. (1987) The influence of chronic stress on multiple opioid systems in the rat: pronounced effects upon dynorphin in the spinal cord. Brain Res. 413, 213-219.
18. Rattan A. K., Koo K. L., Tejwani G. A. and Bhargava H. N. (1992) The effect of morphine tolerance, dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res. 584, 207-212.
19. Romualdi P., Lesa G. and Ferri S. (1991) Chronic opiate agonists down regulate prodynorphin gene expression in rat brain. Brain Res. 563, 132-136.
20. Rossetti Z. L., Hmaidan Y. and Gessa G. L. (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmac. 221, 227-234.
21. Schmauss C. and Herz A. (1987) Intrathecally administered dynorphin (1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-dependent rats. Eur. J. Pharmac. 135, 429-431.
22. Shippenberg T. S., Bals-Kubik R. and Herz A. (1986) Differential effects of μ- and κ-opioid agonists on motivational processes. NIDA Res. Monogr. 75, 563-566.
23. Smith A. J. and McGinty J. F. (1994) Acute amphetamine or metamphetamine alters opioid peptide mRNA expression in rat striatum. Molec. Brain Res. 21, 359-362.
24. Spanagel R., Almeida O. F. X., Bartl C. and Shippenberg T. S. (1994) Endogenous κ-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 115, 121-127.
25. Spanagel R., Herz A. and Shippenberg T. S. (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55, 1734-1740.
26. Spanagel R. and Shippenberg T. S. (1993) Modulation of morphine-induced sensitization by endogenous K opioid systems in the rat. Neurosci. Lett. 153, 232-236.
27. Spangler R., Unterwald E. M. and Kreek M. J. (1993) "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Molec. Brain Res. 19, 323-327.
28. Stinus L., Le Moal M. and Koob G. F. (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37, 767-773.
29. Suzuki T., Narita M., Takahahi Y., Misawa M. and Nagase H. (1992) Effects of nor-binaltorphimine on the development of analgesic tolerance to physical dependence on morphine. Eur. J. Pharmac. 213, 91-97.
30. Takemori A. E., Loh H. H. and Lee N. M. (1992) Supression by dynorphin A (1-13) of the expression of opiate withdrawal and tolerance in mice. Eur. J. Pharmac. 221, 223-226.
31. Trujillo K. A., Bronstein D. M. and Akil H. (1988) Increases in prodynorphin peptides following chronic morphine treatment. Soc. Neurosci. Abstr. 14, 543.
32. Tulunay F. C., Jen M. F., Chang J. K., Loh H. H. and Lee N. M. (1981) Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J. Pharmac. exp. Ther. 219, 296-298.
33. Uhl G. R., Ryan J. P. and Schwartz J. P. (1988) Morphine alters proenkephalin gene expression. Brain Res. 459, 391-397.
34. Yamamoto T., Ohno M. and Ueki S. (1988) A selective κ-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. Eur. J. Pharmac. 156, 173-176.
35. Young W. S., Bonner T. I. and Brann M. R. (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. 83, 9827-9831.